Home ›› 23 Aug 2021 ›› World Biz

Covid-19: India logs 25,072 new cases, 389 deaths

TBP Desk
23 Aug 2021 12:43:40 | Update: 23 Aug 2021 12:43:40
Covid-19: India logs 25,072 new cases, 389 deaths
Healthcare workers and relatives carry a woman from an ambulance for treatment at a Covid-19 care facility, amidst the spread of the coronavirus disease in Mumbai, India, May 4, 2021. — Reuters Photo

India's recorded Monday 25,072 new Covid-19 cases, a drop of nearly 19 per cent from Sunday. About 389 deaths were recorded during the period, according to the Health Ministry.

The daily positivity rate remains less than 3 per cent for the last 28 days and is presently at 1.03 per cent, reports NDTV

Active cases constitute 1.20 per cent of total cases, the lowest since March 2020, while the national Covid-19 recovery rate stands 97.63 per cent, the Union Health Ministry said.

Delhi reported zero daily deaths due to the virus for the third consecutive day on Sunday. Twenty-four new cases of the infection were reported in the national capital, while the positivity rate stood at 0.04 per cent, according to the health department, reported news agency PTI.

This is the 13th time since the beginning of the second wave of the pandemic that Delhi has logged zero fatality due to the disease in a day.

India's Covid-19 vaccination coverage has reached 58 crore with 44 lakh vaccine doses administered till Saturday evening. The country is aiming to inoculate all eligible adults by December.

India has granted emergency use approval for Zydus Cadila's Covid-19 vaccine, the world's first DNA shot against the coronavirus, in adults and children aged 12 years and above. 

The approval gives a boost to India's vaccination programme, which aims to inoculate all eligible adults by December, and will provide the first shot for those under 18, as the country still struggles to contain the virus spread in some states.

Coronavirus cases worldwide have surpassed the 200 million-mark. Cases are rising in about one-third of the world's countries, many of which have not even given half their population a first dose.

×